Therefore, in this study, for the first time, we investigated the relative expression and co-expression and prognostic significance of all members of the HER family with EGFRvIII, and cancer stem cell biomarkers CD44 and CD109 in patients with GBM. The gene discussed is CD44; the disease is glioblastoma.